摘要
CXCR4是一个由352个氨基酸构成的视紫红质样G蛋白偶联受体,趋化因子CXCL12是该受体的唯一配体。目前发现CXCR4在23种不同类型肿瘤中均有表达,并且在肿瘤细胞增殖、浸润、血管新生及转移过程中起到非常重要的作用。针对CXCR4靶向治疗将成为肿瘤基因治疗研究的新热点。
CXCR4 is a 352 amino acid rhodopsin-like G protein-coupled receptor and CXCL12 is the only ligland for CXCR4.At present,malignant cells from 23 different types of cancer express CXCR4,plays an important role in tumor proliferation,infiltration,vascularization and metastasis.CXCR4-targeted therapeutic approaches will become a new hot point in the research of tumor gene therapy.
出处
《复旦学报(医学版)》
CAS
CSCD
北大核心
2008年第2期311-313,318,共4页
Fudan University Journal of Medical Sciences